ONC-108
Enrolling By Invitation
99 years or below
All
Phase
N/A
1 Location
Brief description of study
To evaluate the efficacy of ONC201 administered following radiotherapy in participants with H3 K27Mmutant diffuse glioma. To assess plasma concentrations and
estimate PK parameters for ONC201. To evaluate the efficacy of ONC201
using RANO-LGG criteria. To evaluate the impact of ONC201
treatment on health care resource
utilization.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Updated on
09 Jul 2025.
Study ID: 090720251
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
